Hyperion nets $64.5 million from follow-on offering
This article was originally published in Scrip
Executive Summary
In the follow-on to its $57.5 million initial public offering nine months earlier, Hyperion Therapeutics closed out an offering of 3.3 million shares of common stock at $20.75 per share to raise net proceeds of $64.5 million as of 13 March (scripintelligence.com, 11 March 2013).